313 related articles for article (PubMed ID: 37046996)
1. The Role of miR-128 in Neurodegenerative Diseases.
Lanza M; Cuzzocrea S; Oddo S; Esposito E; Casili G
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37046996
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNA-485 in neurodegenerative diseases.
Ryu IS; Kim DH; Cho HJ; Ryu JH
Rev Neurosci; 2023 Jan; 34(1):49-62. PubMed ID: 35793556
[TBL] [Abstract][Full Text] [Related]
3. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
Ruffini N; Klingenberg S; Schweiger S; Gerber S
Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
[TBL] [Abstract][Full Text] [Related]
4. Current Updates on the Role of MicroRNA in the Diagnosis and Treatment of Neurodegenerative Diseases.
Saleem A; Javed M; Akhtar MF; Sharif A; Akhtar B; Naveed M; Saleem U; Baig MMFA; Zubair HM; Bin Emran T; Saleem M; Ashraf GM
Curr Gene Ther; 2024; 24(2):122-134. PubMed ID: 37861022
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Dysregulated microRNA Biogenesis Machinery and microRNA Sorting on Neurodegenerative Diseases.
Weng YT; Chang YM; Chern Y
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834853
[TBL] [Abstract][Full Text] [Related]
6. lncRNA NEAT1: Key player in neurodegenerative diseases.
Li K; Wang Z
Ageing Res Rev; 2023 Apr; 86():101878. PubMed ID: 36738893
[TBL] [Abstract][Full Text] [Related]
7. Role of Long Non-coding RNAs in the Pathogenesis of Alzheimer's and Parkinson's Diseases.
Sivagurunathan N; Ambatt ATS; Calivarathan L
Curr Aging Sci; 2022; 15(2):84-96. PubMed ID: 35081899
[TBL] [Abstract][Full Text] [Related]
8. The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases.
Klonarakis M; De Vos M; Woo EK; Ralph LT; Thacker JS; Gil-Mohapel J
Neurosci Biobehav Rev; 2022 Apr; 135():104541. PubMed ID: 35063495
[TBL] [Abstract][Full Text] [Related]
9. Human microRNA-4433 (hsa-miR-4443) Targets 18 Genes to be a Risk Factor of Neurodegenerative Diseases.
Ge X; Yao T; Zhang C; Wang Q; Wang X; Xu LC
Curr Alzheimer Res; 2022; 19(7):511-522. PubMed ID: 35929619
[TBL] [Abstract][Full Text] [Related]
10. Interplay between MicroRNAs and Oxidative Stress in Neurodegenerative Diseases.
Konovalova J; Gerasymchuk D; Parkkinen I; Chmielarz P; Domanskyi A
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31801298
[TBL] [Abstract][Full Text] [Related]
11. Histone Methylation Regulation in Neurodegenerative Disorders.
Basavarajappa BS; Subbanna S
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925016
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial abnormalities in neurodegenerative models and possible interventions: Focus on Alzheimer's disease, Parkinson's disease, Huntington's disease.
Pantiya P; Thonusin C; Chattipakorn N; Chattipakorn SC
Mitochondrion; 2020 Nov; 55():14-47. PubMed ID: 32828969
[TBL] [Abstract][Full Text] [Related]
13. Role of connexins in neurodegenerative diseases (Review).
Xing J; Xu C
Mol Med Rep; 2021 May; 23(5):. PubMed ID: 33760195
[TBL] [Abstract][Full Text] [Related]
14. Cognitive performance in healthy clinical trial participants and patients with the NeuroCart, a neurodegenerative disease measured with an automated neuropsychological and neurophysiological test battery.
Prins S; Borghans L; de Kam ML; Groeneveld GJ; van Gerven J
J Neurol Sci; 2023 Jun; 449():120658. PubMed ID: 37079973
[TBL] [Abstract][Full Text] [Related]
15. The Immune System and Neuroinflammation as Potential Sources of Blood-Based Biomarkers for Alzheimer's Disease, Parkinson's Disease, and Huntington's Disease.
Clark LF; Kodadek T
ACS Chem Neurosci; 2016 May; 7(5):520-7. PubMed ID: 27046268
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA Alteration, Application as Biomarkers, and Therapeutic Approaches in Neurodegenerative Diseases.
Nguyen TPN; Kumar M; Fedele E; Bonanno G; Bonifacino T
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563107
[TBL] [Abstract][Full Text] [Related]
17. Research on ferroptosis as a therapeutic target for the treatment of neurodegenerative diseases.
Wang Y; Lv MN; Zhao WJ
Ageing Res Rev; 2023 Nov; 91():102035. PubMed ID: 37619619
[TBL] [Abstract][Full Text] [Related]
18. Dynamic changes in metabolites of the kynurenine pathway in Alzheimer's disease, Parkinson's disease, and Huntington's disease: A systematic Review and meta-analysis.
Fathi M; Vakili K; Yaghoobpoor S; Tavasol A; Jazi K; Hajibeygi R; Shool S; Sodeifian F; Klegeris A; McElhinney A; Tavirani MR; Sayehmiri F
Front Immunol; 2022; 13():997240. PubMed ID: 36263032
[TBL] [Abstract][Full Text] [Related]
19. Specific Signatures of Serum miRNAs as Potential Biomarkers to Discriminate Clinically Similar Neurodegenerative and Vascular-Related Diseases.
Barbagallo C; Mostile G; Baglieri G; Giunta F; Luca A; Raciti L; Zappia M; Purrello M; Ragusa M; Nicoletti A
Cell Mol Neurobiol; 2020 May; 40(4):531-546. PubMed ID: 31691877
[TBL] [Abstract][Full Text] [Related]
20. microRNAs and Neurodegenerative Diseases.
Qiu L; Tan EK; Zeng L
Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
